We found cancer stem cell gene, CD24 (Li et al., 2017) (logFC = 0.9), and therapy resistant genes, CD46 (logFC = 0.3) and CD55 (Zhou et al., 2008) (logFC = 0.4) expressed in ES1, ES2, and ES3 combined, compared to ES0, and cancer stem cell marker, CD59 (Chen et al., 2017) to be the highest in ES1 (logFC = 0.4, Supplementary Figure S2D). This evidence concerns the gene CD46 and cancer.